Targeting Beta Cell Dysfunction With Verapamil in Longstanding T1D

Summary

The purpose of this study is to determine whether verapamil can transiently improve beta cell function in those who do or do not secrete proinsulin and little/no C-peptide.

Timeline

Start

2020-05-30

Primary completion

2021-12-10

Completion

2021-12-10

Publications

• Lord SM, Bahnson HT, Greenbaum CJ, Liljenquist DR, Virostko J, Speake C. Testing a new platform to screen disease-modifying therapy in type 1 diabetes. PLoS One. 2023 Dec 14;18(12):e0293268. doi: 10.1371/journal.pone.0293268. eCollection 2023.

Drugs

Indications